Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine

The aim of the study was to evaluate seizure liability in rats against the convulsant pentylenetetrazole (PTZ) during a 14-day treatment with retigabine (RTG). The seizure liability was also studied on the 1st, 2nd and 3rd day after the abrupt determination of its administration. Male Wistar rats we...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisaveta Apostolova, Vesela Kokova, Lyudmil Peychev
Format: Article
Language:English
Published: Medical University - Pleven 2015-06-01
Series:Journal of Biomedical & Clinical Research
Subjects:
Online Access:https://jbcr.arphahub.com/article/34360/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850068409554829312
author Elisaveta Apostolova
Vesela Kokova
Lyudmil Peychev
author_facet Elisaveta Apostolova
Vesela Kokova
Lyudmil Peychev
author_sort Elisaveta Apostolova
collection DOAJ
description The aim of the study was to evaluate seizure liability in rats against the convulsant pentylenetetrazole (PTZ) during a 14-day treatment with retigabine (RTG). The seizure liability was also studied on the 1st, 2nd and 3rd day after the abrupt determination of its administration. Male Wistar rats were divided in groups of 10 and treated orally for 14 days (1st – 6th group with distilled water, and 7th – 12th group with retigabine (RTG) at a dose of 60 mg/kg bw The tolerance to the anticonvulsant effect of RTG was studied using subcutaneous injection of PTZ (120 mg/kg bw) on the 1th and 14th day. To determine the possible neuronal hyperexcitability on the 1st, 2nd and 3rd day after termination of drug administration, a lower dose of PTZ (65 mg/kg bw) was used. According to our results there was no change in the anticonvulsant activity of RTG during the whole period of treatment. The study on withdrawal syndrome showed slightly decrease of the effect on the first day after the last treatment, but with no significant difference to the controls. The anticonvulsant effect of RTG on the 2nd and 3rd day was close to that in the control group. Our results showed no development of tolerance on subchronic treatment with RTG. There was no significant change in the neuronal hyperexcitability on the 1st, 2nd and 3rd day after the termination of treatment. Based on these results we can suggest that RTG has no potential to develop withdrawal syndrome.
format Article
id doaj-art-e2f78b2206b94def95384615d2c8b992
institution DOAJ
issn 1313-9053
language English
publishDate 2015-06-01
publisher Medical University - Pleven
record_format Article
series Journal of Biomedical & Clinical Research
spelling doaj-art-e2f78b2206b94def95384615d2c8b9922025-08-20T02:48:05ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532015-06-018191210.1515/jbcr-2015-014434360Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With RetigabineElisaveta ApostolovaVesela KokovaLyudmil PeychevThe aim of the study was to evaluate seizure liability in rats against the convulsant pentylenetetrazole (PTZ) during a 14-day treatment with retigabine (RTG). The seizure liability was also studied on the 1st, 2nd and 3rd day after the abrupt determination of its administration. Male Wistar rats were divided in groups of 10 and treated orally for 14 days (1st – 6th group with distilled water, and 7th – 12th group with retigabine (RTG) at a dose of 60 mg/kg bw The tolerance to the anticonvulsant effect of RTG was studied using subcutaneous injection of PTZ (120 mg/kg bw) on the 1th and 14th day. To determine the possible neuronal hyperexcitability on the 1st, 2nd and 3rd day after termination of drug administration, a lower dose of PTZ (65 mg/kg bw) was used. According to our results there was no change in the anticonvulsant activity of RTG during the whole period of treatment. The study on withdrawal syndrome showed slightly decrease of the effect on the first day after the last treatment, but with no significant difference to the controls. The anticonvulsant effect of RTG on the 2nd and 3rd day was close to that in the control group. Our results showed no development of tolerance on subchronic treatment with RTG. There was no significant change in the neuronal hyperexcitability on the 1st, 2nd and 3rd day after the termination of treatment. Based on these results we can suggest that RTG has no potential to develop withdrawal syndrome.https://jbcr.arphahub.com/article/34360/download/pdf/retigabinetolerancewithdrawalPTZrats
spellingShingle Elisaveta Apostolova
Vesela Kokova
Lyudmil Peychev
Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine
Journal of Biomedical & Clinical Research
retigabine
tolerance
withdrawal
PTZ
rats
title Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine
title_full Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine
title_fullStr Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine
title_full_unstemmed Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine
title_short Experimental Study On The Development Of Tolerance And Withdrawal Syndrome To Pentylenetetrazole-Induced Seizures In Rats Treated With Retigabine
title_sort experimental study on the development of tolerance and withdrawal syndrome to pentylenetetrazole induced seizures in rats treated with retigabine
topic retigabine
tolerance
withdrawal
PTZ
rats
url https://jbcr.arphahub.com/article/34360/download/pdf/
work_keys_str_mv AT elisavetaapostolova experimentalstudyonthedevelopmentoftoleranceandwithdrawalsyndrometopentylenetetrazoleinducedseizuresinratstreatedwithretigabine
AT veselakokova experimentalstudyonthedevelopmentoftoleranceandwithdrawalsyndrometopentylenetetrazoleinducedseizuresinratstreatedwithretigabine
AT lyudmilpeychev experimentalstudyonthedevelopmentoftoleranceandwithdrawalsyndrometopentylenetetrazoleinducedseizuresinratstreatedwithretigabine